ATE175960T1 - Neue alpha-mannosidase-inhibitoren - Google Patents

Neue alpha-mannosidase-inhibitoren

Info

Publication number
ATE175960T1
ATE175960T1 AT92918131T AT92918131T ATE175960T1 AT E175960 T1 ATE175960 T1 AT E175960T1 AT 92918131 T AT92918131 T AT 92918131T AT 92918131 T AT92918131 T AT 92918131T AT E175960 T1 ATE175960 T1 AT E175960T1
Authority
AT
Austria
Prior art keywords
alpha
beta
new alpha
mannosidase inhibitors
mannosidase
Prior art date
Application number
AT92918131T
Other languages
English (en)
Inventor
Robert A Farr
Mohinder S Kang
Norton P Peet
Sai P Sunkara
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE175960T1 publication Critical patent/ATE175960T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92918131T 1991-09-18 1992-08-10 Neue alpha-mannosidase-inhibitoren ATE175960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76157991A 1991-09-18 1991-09-18
US07/893,171 US5262425A (en) 1991-09-18 1992-06-03 α-mannosidase inhibitors

Publications (1)

Publication Number Publication Date
ATE175960T1 true ATE175960T1 (de) 1999-02-15

Family

ID=27117010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918131T ATE175960T1 (de) 1991-09-18 1992-08-10 Neue alpha-mannosidase-inhibitoren

Country Status (15)

Country Link
US (1) US5262425A (de)
EP (1) EP0641327B1 (de)
JP (1) JP3226173B2 (de)
KR (1) KR100244012B1 (de)
AT (1) ATE175960T1 (de)
AU (1) AU659486B2 (de)
CA (1) CA2116224C (de)
DE (1) DE69228259T2 (de)
DK (1) DK0641327T3 (de)
ES (1) ES2127758T3 (de)
FI (1) FI105270B (de)
GR (1) GR3029745T3 (de)
HU (1) HU216789B (de)
NO (1) NO300372B1 (de)
WO (1) WO1993005781A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
WO1999021858A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031102A (en) * 1972-10-21 1977-06-21 John Wyeth & Brother Limited Cyclopenteno[b]pyridine derivatives
GB2088860B (en) * 1980-12-09 1984-05-23 Wyeth John & Brother Ltd Process for preparing ring-fused pyridine derivatives

Also Published As

Publication number Publication date
AU2477192A (en) 1993-04-27
NO300372B1 (no) 1997-05-20
JPH06510785A (ja) 1994-12-01
JP3226173B2 (ja) 2001-11-05
WO1993005781A1 (en) 1993-04-01
AU659486B2 (en) 1995-05-18
FI941259L (fi) 1994-03-17
DK0641327T3 (da) 1999-09-13
GR3029745T3 (en) 1999-06-30
EP0641327A1 (de) 1995-03-08
ES2127758T3 (es) 1999-05-01
CA2116224A1 (en) 1993-04-01
US5262425A (en) 1993-11-16
HU216789B (hu) 1999-08-30
KR100244012B1 (ko) 2000-03-02
EP0641327A4 (de) 1994-06-01
EP0641327B1 (de) 1999-01-20
NO940972L (no) 1994-03-17
NO940972D0 (no) 1994-03-17
HUT70527A (en) 1995-10-30
FI941259A0 (fi) 1994-03-17
HU9400787D0 (en) 1994-06-28
FI105270B (fi) 2000-07-14
CA2116224C (en) 2003-06-03
DE69228259D1 (de) 1999-03-04
DE69228259T2 (de) 1999-06-02

Similar Documents

Publication Publication Date Title
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
DE69516866D1 (de) Stereochemische wortmanninderivate
CO4290353A1 (es) Agonistas de estrogeno
FI954738A7 (fi) Tetrasykliini yhdisteet dopamiiniagonisteina
MX9202748A (es) Compuesto de arileter, proceso para su obtencion y composicion farmaceutica que los contiene.
NO944406L (no) Nye 7 e inhibitorer
DE69230509D1 (de) Entferner für keratinöse Komedonen
DE69228259D1 (de) Neue alpha-mannosidase-inhibitoren
SE9600120D0 (sv) Novel medical use
ITVR910067A1 (it) Fissatore esterno assiale per la composizione di fratture ossee
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
DK0451834T3 (da) alfa-Mannosidase- og fucosidase-hæmmere
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
KR960003469U (ko) 브라운관의 이.엠.아이(emi) 차단장치
FI922016A0 (fi) Foerfarande foer framstaellning av dubbelskyddade 1-karba(1-detia)-3-kefem-4-karboxylsyror.
DK0539451T3 (da) Vinylsulfonyl-pristinamycin og dets fremstilling
ITRM940151A0 (it) Impiego di esteruretani per la riconcia.
IT9047682A1 (it) Composizione sterilizzatrice e procedimento per il suo impiego.
KR930019933U (ko) 반원형 고정체를 이용한 실린더정
IT8882616A0 (it) Metodo per l'applicazione di una schermatura particolarmente sulle lampade dicroiche
ES2065843A1 (es) Aplicacion de ent-11 , 16-dihidroxi-18-nor-4a -carboximetil-oxido de manoilo como inhibidor de la adenilatociclasa.
IT222255Z2 (it) Vestito sterile per intensificatore di brillanza
KR960003467U (ko) 브라운관의 이.엠.아이(emi) 차단장치

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee